Rafferty Asset Management’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
105,374
-99,174
-48% -$1.07M ﹤0.01% 694
2026
Q1
$1.73M Sell
204,548
-4,758
-2% -$52.1K 0.01% 640
2025
Q4
$2.36M Buy
209,306
+45,737
+28% +$567K 0.01% 612
2025
Q3
$2.46M Buy
163,569
+42,380
+35% +$617K 0.01% 600
2025
Q2
$1.71M Buy
121,189
+1,503
+1% +$26.8K 0.01% 639
2025
Q1
$2.88M Sell
119,686
-15,570
-12% -$549K 0.01% 487
2024
Q4
$5.05M Sell
135,256
-2,295
-2% -$107K 0.02% 415
2024
Q3
$6.87M Sell
137,551
-58,109
-30% -$2.26M 0.02% 348
2024
Q2
$6.79M Buy
195,660
+37,468
+24% +$1.48M 0.03% 353
2024
Q1
$8.65M Sell
158,192
-113,385
-42% -$5.61M 0.03% 322
2023
Q4
$11.6M Sell
271,577
-71,284
-21% -$2.22M 0.05% 234
2023
Q3
$8.92M Buy
342,861
+153,271
+81% +$3.19M 0.05% 252
2023
Q2
$4.53M Sell
189,590
-166,754
-47% -$2.87M 0.03% 439
2023
Q1
$4.87M Sell
356,344
-3,888
-1% -$61.9K 0.03% 389
2022
Q4
$5M Buy
+360,232
New +$5.09M 0.04% 374

Other funds holding BHVN

Rafferty Asset Management's BHVN Position: Q2 2026 in Review

Rafferty Asset Management reduced its Biohaven (BHVN) stake by 48% in Q2 2026, selling an estimated $1.07M and leaving 105,374 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #694.

Rafferty Asset Management first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $11.6M in Q4 2023. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Rafferty Asset Management held 105,374 shares of Biohaven worth $1.57M as of Q2 2026.
  • Rafferty Asset Management sold 99,174 Biohaven shares in Q2 2026, an estimated $1.07M.
  • Biohaven made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #694 holding.
  • Rafferty Asset Management first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Rafferty Asset Management's Biohaven position peaked at $11.6M in Q4 2023.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.